Sole source award of a 24-month period, firm fixed price (FFP), ends toxicological studies for center for tobacco products (CTP).
Active Purchase Order Awarded
- Contract number
- 75F40125P00216
- Awardee
-
Lovelace Biomedical Research Institute UEI MBT9RXJJ7428
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $7,058,882
Award facts
- Opportunity
-
- 75F40125Q00346 Solicitation number
- Contract value 100% obligated
- $7,058,881.75 Current and potential, with all options
- Completion date 56% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541380 Testing Laboratories and Services
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Albuquerque, NM 87108, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
This is a sole source, firm fixed-price contract awarded by the Food and Drug Administration (FDA) to the Lovelace Biomedical Research Institute, a not-for-profit contract research organization located in Albuquerque, New Mexico. The 24-month contract, valued at $7,058,881.75, is for the completion of toxicological studies for the FDA's Center for Tobacco Products. The award is not set aside for any small business category. Lovelace Biomedical Research Institute has significant experience providing comprehensive research and development services to federal agencies, including animal studies, analytical testing, and preclinical product development across various therapeutic areas. The organization holds multiple Indefinite Delivery/Indefinite Quantity (IDIQ) contracts with agencies such as the National Institutes of Health, Office of the Assistant Secretary for Preparedness and Response, and National Institute on Drug Abuse, demonstrating its versatility in supporting complex federal research and development needs.
Quick answers
Who was awarded contract 75F40125P00216?
75F40125P00216 was awarded to Lovelace Biomedical Research Institute by Food and Drug Administration (Department of Health and Human Services) on September 19, 2025.
How much is contract 75F40125P00216 worth?
The government has obligated $7,058,882 on 75F40125P00216.
Was contract 75F40125P00216 competed?
The extent of competition for 75F40125P00216 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award